Loading company…
Synceres Biosciences researches and applies synthetic biotechnology.
Synceres Biosciences researches and develops synthetic biotechnology for applications including healthcare, medication, skincare, and materials. The company and Angel yeast Co., Ltd. jointly established Hubei angel senris Biotechnology Co., Ltd. in May 2021. In June 2023, Synceres raised Series A+ funding as part of a larger CNY 100 million Series A round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in